Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban Monotherapy in AF with Stable CAD (AFIRE)
NCT02642419Phase 4Unknown
- Sponsor
- Japan Cardiovascular Research Foundation
- Start
- Jan 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of rivaroxaban in Atrial fibrillation (AFib), coronary artery disease (CAD), sponsored by Japan Cardiovascular Research Foundation. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT02642419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02642419.